{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:25:40Z","timestamp":1787955940235,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3523-9","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T01:07:36Z","timestamp":1543453656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem"],"prefix":"10.1186","volume":"18","author":[{"given":"Brian Arturo","family":"Mondeja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Couri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Maria","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestes","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7435","authenticated-orcid":false,"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"3523_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2016.268","volume":"14","author":"M Unemo","year":"2017","unstructured":"Unemo M, Jensen JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol. 2017;14:139\u201352.","journal-title":"Nat Rev Urol"},{"key":"3523_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/593188","volume":"47","author":"JS Jensen","year":"2008","unstructured":"Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47:1546\u201353.","journal-title":"Clin Infect Dis"},{"key":"3523_CR3","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1128\/AAC.02411-14","volume":"58","author":"JS Jensen","year":"2014","unstructured":"Jensen JS, Fernandes P, Unemo M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and - susceptible Mycoplasma genitalium strains. Antimicrob Agents Chemother. 2014;58:3151\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"3523_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cid\/ciu217","volume":"59","author":"K Salado-Rasmussen","year":"2014","unstructured":"Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis. 2014;59:24\u201330.","journal-title":"Clin Infect Dis"},{"key":"3523_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/ijch.v71i0.18203","volume":"71","author":"DC Gesink","year":"2012","unstructured":"Gesink DC, Mulvad G, Montgomery-Andersen R, Poppel U, Montgomery-Andersen S, Binzer A, et al. Mycoplasma genitalium presence resistance and epidemiology in Greenland. Int J Circumpolar Health. 2012;71:1\u20138.","journal-title":"Int J Circumpolar Health"},{"key":"3523_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/cid\/cit752","volume":"58","author":"MJ Pond","year":"2014","unstructured":"Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD, Sadiq ST. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis. 2014;58:631\u20137.","journal-title":"Clin Infect Dis"},{"key":"3523_CR7","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/jac\/dkv136","volume":"70","author":"RH Nijhuis","year":"2015","unstructured":"Nijhuis RH, Severs TT, Van der Vegt DS, Van Zwet AA, Kusters JG. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. J Antimicrob Chemother. 2015;70:2515\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"3523_CR8","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1128\/JCM.00495-13","volume":"51","author":"KA Tagg","year":"2013","unstructured":"Tagg KA, Jeoffreys NJ, Couldwell DL, Donald JA, Gilbert GL. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol. 2013;51:2245\u20139.","journal-title":"J Clin Microbiol"},{"key":"3523_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/JCM.34.2.286-291.1996","volume":"34","author":"JS Jensen","year":"1996","unstructured":"Jensen JS, Hansen HT, Lind K. Isolation of Mycoplasma genitalium strains from the male urethra. J Clin Microbiol. 1996;34:286\u201391.","journal-title":"J Clin Microbiol"},{"key":"3523_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162924","volume":"11","author":"BA Mondeja","year":"2016","unstructured":"Mondeja BA, Rodriguez NM, Barroto B, Blanco O, Jensen JS. Antimicrobial susceptibility patterns of recent Cuban Mycoplasma genitalium isolates determined by a modified cell-culture-based method. PLoS One. 2016;11:e0162924.","journal-title":"PLoS One"},{"key":"3523_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1128\/JCM.42.2.683-692.2004","volume":"42","author":"JS Jensen","year":"2004","unstructured":"Jensen JS, Bj\u00f6rnelius E, Dohn B, Lidbrink P. Use of TaqMan 5\u2019 nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol. 2004;42:683\u201392.","journal-title":"J Clin Microbiol"},{"key":"3523_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1128\/JCM.41.1.261-266.2003","volume":"41","author":"JS Jensen","year":"2003","unstructured":"Jensen JS, Borre MB, Dohn B. Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene. J Clin Microbiol. 2003;41:261\u20136.","journal-title":"J Clin Microbiol"},{"key":"3523_CR13","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1128\/IAI.00819-12","volume":"80","author":"CL McGowin","year":"2012","unstructured":"McGowin CL, Annan RS, Quayle AJ, Greene SJ, Ma L, Mancuso MM, et al. Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun. 2012;80:3842\u20139.","journal-title":"Infect Immun"},{"key":"3523_CR14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1128\/JCM.00012-16","volume":"54","author":"GQ Kristiansen","year":"2016","unstructured":"Kristiansen GQ, Lisby JG, Schonning K. A 5\u2019 nuclease genotyping assay for identification of macrolide-resistant Mycoplasma genitalium in clinical specimens. J Clin Microbiol. 2016;54:1593\u20137.","journal-title":"J Clin Microbiol"},{"key":"3523_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-61779-937-2_8","volume-title":"Diagnosis of Sexually Transmitted Diseases; Methods and Protocols","author":"JS Jensen","year":"2012","unstructured":"Jensen JS. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. In: CR MK, Henrich B, editors. Diagnosis of Sexually Transmitted Diseases; Methods and Protocols. 903rd ed. New York: Humana Press, Springer; 2012. p. 129\u201339.","edition":"903"},{"key":"3523_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/2052-2975.20","volume":"1","author":"BA Mondeja","year":"2013","unstructured":"Mondeja BA, Jensen JS, Rodriguez I, Morier LF, Kouri V, Rodriguez NM, et al. Isolation of mycoplasma genitalium from patients with urogenital infections: first report from the Latin-American region. New Microbes New Infect. 2013;1:22\u20136.","journal-title":"New Microbes New Infect"},{"key":"3523_CR17","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1128\/JCM.00003-06","volume":"44","author":"SV Hjorth","year":"2006","unstructured":"Hjorth SV, Bj\u00f6rnelius E, Lidbrink P, Falk L, Dohn B, Berthelsen L, et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol. 2006;44:2078\u201383.","journal-title":"J Clin Microbiol"},{"key":"3523_CR18","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","volume":"49","author":"R Hamasuna","year":"2005","unstructured":"Hamasuna R, Osada Y, Jensen JS. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5\u2032 nuclease real-time PCR. Antimicrob Agents Chemother. 2005;49:4993\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"3523_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1\u2013137.","journal-title":"MMWR Recomm Rep"},{"key":"3523_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/jdv.13849","volume":"30","author":"JS Jensen","year":"2016","unstructured":"Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30:1650\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3523_CR21","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1128\/JCM.00232-10","volume":"48","author":"KH Carlsen","year":"2010","unstructured":"Carlsen KH, Jensen JS. Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? J Clin Microbiol. 2010;48:3624\u20137.","journal-title":"J Clin Microbiol"},{"key":"3523_CR22","unstructured":"CLSI (Eds):Methods for antimicrobial susceptibility testing for human mycoplasmas; Approved guideline. In CLSI document 2011, M43-A."},{"key":"3523_CR23","doi-asserted-by":"publisher","first-page":"S412","DOI":"10.1093\/infdis\/jix132","volume":"216","author":"CS Bradshaw","year":"2017","unstructured":"Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment. J Infect Dis. 2017;216:S412\u20139.","journal-title":"J Infect Dis"},{"key":"3523_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12879-015-1041-6","volume":"15","author":"JS Jensen","year":"2015","unstructured":"Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015;15:343.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3523-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T07:15:35Z","timestamp":1605510935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3523-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3523-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by The Pedro Kour\u00ed Tropical Medicine Institute Ethical Board (approval CEI-IPK 57\u201316) and written informed consent to participate and publish was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"BM, JC, NM, OB, and CF report no conflict of interest. JSJ has received speaker\u2019s fee from Hologic and serves a scientific advisory board of Roche Molecular Systems. SSI has received remuneration for contract work from SpeeDx, Hologic, NYTor, Diagenode, Nabriva, GSK, and Angelini.The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"601"}}